Tharimmune raises $545 million in private placement, appoints new CEO and president
PositiveFinancial Markets

Tharimmune raises $545 million in private placement, appoints new CEO and president
Tharimmune has successfully raised $545 million in a private placement, marking a significant milestone for the company as it seeks to advance its innovative therapies. This funding will not only bolster its research and development efforts but also comes alongside the appointment of a new CEO and president, signaling a fresh leadership direction. This is an exciting time for Tharimmune, as the new capital and leadership could enhance its position in the competitive biotech landscape.
— via World Pulse Now AI Editorial System







